Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine PK/PD and Efficacy in Seasonal Allergic Rhinitis (EEC Model)
NCT00574210Phase 2Completed
- Sponsor
- Faes Farma
- Start
- Oct 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bilastine in seasonal allergic rhinitis (SAR) (5 arms), sponsored by Faes Farma. Primary endpoint: Total Nasal Symptom Scores at 10 days. Started Oct 2007; status: completed.
02
Drugs
bilastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00574210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574210.